- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.12. | NEXSEN LIMITED: Investor Presentation | - | ASX | ||
| 05.12. | NEXSEN LIMITED: Initial Directors Interest Notice - Kumta | - | ASX | ||
| 02.12. | NEXSEN LIMITED: Nexsen Appoints Global Clinical Leader to the Board | - | ASX | ||
| NEXSEN Aktie jetzt für 0€ handeln | |||||
| 21.11. | NEXSEN LIMITED: Results of AGM | 1 | ASX | ||
| 20.11. | NEXSEN LIMITED: Chairman's Address to AGM | - | ASX | ||
| 05.11. | NEXSEN LIMITED: Nexsen accelerates US diagnostics market entry | - | ASX | ||
| 31.10. | NEXSEN LIMITED: Quarterly Report - Q1 FY26 | 1 | ASX | ||
| 23.10. | NEXSEN LIMITED: Notice of Annual General Meeting | - | ASX | ||
| 21.10. | NEXSEN LIMITED: Nexsen launches clinical trial for GBS Rapid Sensor | - | ASX | ||
| 15.10. | NEXSEN LIMITED: Becoming a substantial holder | - | ASX | ||
| 14.10. | Closing Bell: ASX bounces to the finish line as Nexsen shines on debut | 1 | Stockhead | ||
| 14.10. | NEXSEN LIMITED: Directors Interest Notices | - | ASX | ||
| 14.10. | NEXSEN LIMITED: Nexsen sucessfully lists on ASX | - | ASX | ||
| 14.10. | NEXSEN LIMITED: Becoming a substantial holder - Muzzin | - | ASX | ||
| 14.10. | NEXSEN LIMITED: Becoming a substantial holder - Nexsen | - | ASX | ||
| 10.10. | NEXSEN LIMITED: Pre Quotation Disclosures | 1 | ASX | ||
| 10.10. | NEXSEN LIMITED: Top 20 Holders | 2 | ASX | ||
| 10.10. | NEXSEN LIMITED: Distribution Schedule | 1 | ASX | ||
| 10.10. | NEXSEN LIMITED: Securities Trading Policy | - | ASX | ||
| 10.10. | NEXSEN LIMITED: Corporate Governance Statement | - | ASX |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 23,750 | +1,93 % | Formycon AG: Deal-Aktivität und Pipeline-Fortschritte stützen Jahresziele; KAUFEN. | Formycon tritt in das vierte Quartal mit kommerzieller Dynamik ein, unterstützt durch regionale Lizenzabschlüsse für FYB206 (Keytruda, Pembrolizumab) mit MS Pharma und Zydus Lifesciences sowie durch... ► Artikel lesen | |
| ONTO INNOVATION | 126,00 | -4,55 % | Onto Innovation Inc. (ONTO): A Bull Case Theory | ||
| GAUZY | 1,170 | +2,63 % | Faruqi & Faruqi LLP: GAUZ INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Gauzy | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Gauzy To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired... ► Artikel lesen | |
| VEECO INSTRUMENTS | 26,400 | +1,54 % | Veeco Instruments Inc.: Veeco Reports Third Quarter 2025 Financial Results | Third Quarter 2025 Highlights: Revenue of $165.9 million, compared with $184.8 million in the same period last yearGAAP net income of $10.6 million, or $0.17 per diluted share, compared with $22.0... ► Artikel lesen | |
| GOMSPACE | 1,346 | -1,90 % | GomSpace to provide RF subsystem for Apolink LEO relay demonstrator | ||
| KOPIN | 2,010 | -5,72 % | Kopin Corporation: Michael Murray, Kopin's CEO to Present at THEON International's Capital Markets Day (CMD) on November 6, 2025 | Kopin Corporation (NASDAQ: KOPN), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical... ► Artikel lesen | |
| SOLESENCE | 1,910 | -3,05 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| RIBER | 3,270 | -3,25 % | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook | 2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook. Half-year revenues and earnings, particularly marked by seasonal activity patterns. Order book of €27.7m... ► Artikel lesen | |
| FENDX TECHNOLOGIES | 0,308 | -3,75 % | FendX Technologies Inc.: FendX Provides Corporate Update | Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D0) (the "Company" or "FendX"), an innovative surface protection company... ► Artikel lesen | |
| NANOFOCUS | 1,850 | 0,00 % | HV-Termine: Hauptversammlungen bei bioXXmed, Borussia Dortmund, CureVac, elexxion, Nanofocus, NSI Asset, OTRS | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
| ACACIA RESEARCH | 3,140 | +1,29 % | Acacia Research Non-GAAP EPS of -$0.01 beats by $0.13, revenue of $59.4M beats by $21.4M | ||
| ADVANCE ZINCTEK | 0,520 | 0,00 % | ADVANCE ZINCTEK LIMITED: Response to Television Broadcast Early This Week | ||
| LAMPETIA | 0,068 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| NANOVIRICIDES | 1,020 | +6,25 % | NanoViricides Has Signed a Master Services Agreement with OnlyOrphansCote Regarding Orphan Drug Strategy of NV-387 for Treatment of MPox, Smallpox, and Measles | SHELTON, CONNECTICUT / ACCESS Newswire / December 1, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development... ► Artikel lesen | |
| REGION GROUP | 1,312 | 0,00 % | Region Group grows property valuations in December 2025 update |
NEXSEN LIMITED gehört der Branche Nanotechnologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXSEN LIMITED finden Sie auf Wallstreet Online.